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Introduction
Adiponection (ADP) and leptin (LEP) are adipokines
with roles in inflammation.
Aim
To assess ADP and LEP levels before and after acute
abortive treatment in episodic migraineurs (EM).
Methods
Peripheral blood specimens were collected from EM
participants before and after acute abortive treatment
with sumatriptan/naproxen sodium versus placebo.
Results
A total of 34 participants (17 responders, 17 non-
responders) were included. In all participants, for every
1 point increase in the HMW:T-ADP ratio, pain severity
increased by 4.11 (CI: 0.44, 7.77; p = 0.028). In responders
(n = 17), crude T-ADP levels were reduced at 30 min
(11.49 ± 3.7; p = 0.001), 60 min (11.54 ± 3.2; p = 0.001)
and 120 min (11.39 ± 3.7; p = 0.001) after treatment as
compared to onset (12.47 ± 3.6). In non-responders (n =
17), crude T-ADP levels were unchanged after treatment.
After adjustments, T-ADP levels remained decreased 30-
120 min after treatment in responders; additionally,
HMW-ADP, and the HMW:T-ADP ratio were decreased
and LMW-ADP and the LMW:T-ADP ratio (coeff 0.04;
CI: 0.01, 0.07; p = 0.043) were increased 120 min after
treatment in responders. In non-responders, the adjusted
LMW-ADP (coef -0.45; CI: -0.77, -0.14; p = 0.005) and the
LMW:T-ADP ratio (coef -0.04; CI: -0.07, -0.01; p = 0.018)
were decreased at 60 min as well as at 120 min after
treatment. Unadjusted and adjusted LEP levels were not
modulated by changes in pain severity or treatment
response.
Conclusion
Adiponectin, but not leptin, is associated with pain
severity and is modulated by treatment response in epi-
sodic migraineurs.
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